PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

PAR General discussion, page-204

  1. 342 Posts.
    lightbulb Created with Sketch. 14
    Thanks Iken, so looking at the phase 3 trial they have already started screening participants? my understanding was that the trial would not be starting until the end of this year at the earliest
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.